Breaking News, Promotions & Moves

Harbour BioMed Appoints Michael D. Patten Chief Strategy Officer

Patten will also serve as the Head of Global Alliance and lead efforts to manage and strengthen the company’s partner network.

By: Rachel Klemovitch

Assistant Editor

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology, has appointed Michael D. Patten as Chief Strategy Officer. Patten will be based in the United States and report directly to Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed. Patten will be responsible for formulating and overseeing the global corporate development and growth strategy for the company. He w...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters